LivaNova Management
Management Kriterienprüfungen 2/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Wichtige Informationen
Vladimir Makatsaria
Geschäftsführender
n/a
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | n/a |
| Amtszeit als Geschäftsführer | less than a year |
| Eigentum des Geschäftsführers | n/a |
| Durchschnittliche Amtszeit des Managements | 2yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 3.2yrs |
Jüngste Management Updates
Recent updates
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 12
LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Nov 03LivaNova (NASDAQ:LIVN) Is Experiencing Growth In Returns On Capital
Oct 31LivaNova: Economics Should Start Making Sustained Improvements
Oct 18Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 31%?
Oct 02LivaNova PLC's (NASDAQ:LIVN) Prospects Need A Boost To Lift Shares
Aug 21LivaNova (NASDAQ:LIVN) Might Have The Makings Of A Multi-Bagger
Jul 30At US$52.79, Is It Time To Put LivaNova PLC (NASDAQ:LIVN) On Your Watch List?
Jul 04Is LivaNova PLC (NASDAQ:LIVN) Trading At A 31% Discount?
Jun 13LivaNova: Focus Is Paying Off
May 12These Return Metrics Don't Make LivaNova (NASDAQ:LIVN) Look Too Strong
Apr 08Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?
Feb 05A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)
Jan 15LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry
Dec 25LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company
Nov 29We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 08At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
Oct 16Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?
Sep 25Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
Jul 26Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?
Jul 03An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued
Jun 09Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital
Apr 13What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?
Mar 13Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Feb 15Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up
Nov 25Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Oct 29LivaNova Loses Profit Momentum On Higher R&D Expense
Oct 13LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate
Oct 11FDA labels recall of blood bypass pump systems by LivaNova as most serious
Sep 30Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes
Aug 09LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance
Aug 03Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Jul 19Geschäftsführer
Vladimir Makatsaria (51 yo)
less than a year
Amtszeit
Mr. Vladimir A. Makatsaria has been the Chief Executive Officer and Director at LivaNova PLC since March 01, 2024. He is a Non-Executive Director of the Health Products Regulatory Authority Board in Irelan...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Chief Financial Officer | 4yrs | US$2.77m | 0.034% $ 979.9k | |
| Senior VP | 2yrs | US$2.07m | 0.0042% $ 119.6k | |
| CEO & Director | less than a year | keine Daten | keine Daten | |
| Senior Director of Investor Relations | no data | keine Daten | keine Daten | |
| Vice President of Corporate Communications | no data | keine Daten | keine Daten | |
| Senior Vice President of Corporate Development & IT | 6.8yrs | keine Daten | keine Daten | |
| President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement | no data | keine Daten | keine Daten | |
| President of Global Epilepsy | 4.8yrs | keine Daten | 0.018% $ 500.3k | |
| Chief Innovation Officer | less than a year | keine Daten | keine Daten | |
| President of Cardiopulmonary Business Unit | less than a year | keine Daten | 0.013% $ 360.2k | |
| Vice President of Sleep Apnea and Epilepsy | no data | keine Daten | keine Daten | |
| VP for Difficult-to-Treat Depression Segment | no data | keine Daten | keine Daten |
2.0yrs
Durchschnittliche Betriebszugehörigkeit
53yo
Durchschnittliches Alter
Erfahrenes Management: LIVNDas Führungsteam des Unternehmens gilt als erfahren (2 Jahre durchschnittliche Betriebszugehörigkeit).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Director | less than a year | keine Daten | keine Daten | |
| Independent Non-Executive Director | 3.9yrs | US$270.00k | 0.011% $ 316.8k | |
| Independent Director | 2.4yrs | US$263.00k | 0.0069% $ 195.2k | |
| Chairman of Board | 6.4yrs | US$3.34m | 0.051% $ 1.4m | |
| Independent Non-Executive Director | 9.1yrs | US$281.43k | 0.017% $ 496.6k | |
| Independent Non-Executive Director | 5.4yrs | US$260.00k | 0.016% $ 457.4k | |
| Independent Non-Executive Director | 9.1yrs | US$263.00k | 0.016% $ 458.8k | |
| Independent Director | less than a year | keine Daten | keine Daten | |
| Independent Director | 1.1yrs | US$117.88k | keine Daten | |
| Independent Director | 2.2yrs | US$248.00k | 0.0064% $ 181.8k |
3.2yrs
Durchschnittliche Betriebszugehörigkeit
60.5yo
Durchschnittliches Alter
Erfahrener Vorstand: LIVNDie Vorstandsmitglieder gelten als erfahren (3.2 Jahre durchschnittliche Amtszeit).